Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis
Open Access
- 29 April 2020
- journal article
- research article
- Published by American Society for Microbiology in mSphere
- Vol. 5 (2)
Abstract
Antibiotic efficacy achieved in vitro correlates poorly with clinical outcomes after treatment of chronic polymicrobial diseases; if a pathogen demonstrates susceptibility to a given antibiotic in the lab, that compound is often ineffective when administered clinically. Conversely, if a pathogen is resistant in vitro , patient treatment with that same compound can elicit a positive response. This discordance suggests that the in vivo growth environment impacts pathogen antibiotic susceptibility. Indeed, here we demonstrate that interspecies relationships among microbiotas in the sputa of cystic fibrosis patients can be targeted to indirectly inhibit the growth of Pseudomonas aeruginosa . The therapeutic implication is that control of chronic lung infections may be achieved by exploiting obligate or facultative relationships among airway bacterial community members. This strategy is particularly relevant for pathogens harboring intrinsic multidrug resistance and is broadly applicable to chronic polymicrobial airway, wound, and intra-abdominal infections.Keywords
Funding Information
- Gilead Sciences
- HHS | NIH | National Heart, Lung, and Blood Institute (1HL136919)
- Cystic Fibrosis Foundation (FLYNN16F0)
- American Society for Microbiology
This publication has 16 references indexed in Scilit:
- Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practicesJournal of Cystic Fibrosis, 2020
- Reactive oxygen species induce antibiotic tolerance during systemic Staphylococcus aureus infectionNature Microbiology, 2019
- Reconciling Antimicrobial Susceptibility Testing and Clinical Response in Antimicrobial Treatment of Chronic Cystic Fibrosis Lung InfectionsClinical Infectious Diseases, 2019
- Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic reviewJournal of Cystic Fibrosis, 2019
- Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureusPLOS Biology, 2017
- Production of extended-spectrum β -lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiotaInternational Journal of Antimicrobial Agents, 2016
- Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide FormationmBio, 2015
- Polymorphonuclear Leukocytes Restrict Growth of Pseudomonas aeruginosa in the Lungs of Cystic Fibrosis PatientsInfection and Immunity, 2014
- Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosisJournal of Cystic Fibrosis, 2012
- Susceptibility Testing of Pseudomonas aeruginosa Isolates and Clinical Response to Parenteral Antibiotic AdministrationChest, 2003